- Cardiorenal Syndrome (Clinical Implications and Treatment Strategies)
- Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? What is the Evidence?
- Refractory Edema with CHF - Stepwise Approaches - Nephrology Perspectives
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
- SGLT2-i, DPP4-i & Incretin Mimetics (Optimizing their use in CKD Patients)
- Is It Diabetic Nephropathy? (When to Biopsy?)
- Challenges in Diagnosis and Management of Diabetic Kidney Disease
- Thrombotic Microangiopathy (TMA) in Adults and AKI
- Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside)
- Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinemia), Nephrology Perspective
- Metabolic Nephropathy
- Uric acid and CKD (Consequences, Management and Evidence)
- Lupus Nephritis Management (The Soft Evidence)